Mattress ticking specialist anti-viral treatment efficacy

• April 22, 2021

Waregem - Circular knitter BekaertDeslee has confirmed that its new anti-viral treatment technology for its mattress ticking products reduces the viral activity of SARS-CoV-2 by 99.97 per cent after two hours.

Virase is the latest addition to the company's Sleep Dimension ‘Clean’ family of products, which is designed to provide a fresh and healthy long lasting hygienic sleep environment.

The company says it is first in the industry to provide proof of a higher than 99 per cent reduction (a 2-Log reduction) of viral activity within two hours on the surface of an in-house produced mattress textile although variances are possible depending on the fabric construction.

Bekaertdeslee tested the Virase treatment in an independent European lab for its efficacy against the SARS-CoV-2 virus on in-house produced mattress textiles. Results confirmed an instant (2 hours) efficacy (99.97% reduction) of the Virase treatment on both polyester and polyester viscose fabrics.

The test protocol was executed in accordance with the international standard for determination of antiviral activity of textile products, ISO 18184.

BekaertDeslee has also launched PPPRMNT, a natural antimicrobial finish that offers protection against bacteria and dust mites. By inhibiting their growth, PPPRMNT is said to deliver a safe and environmental solution to keep mattresses fresh and clean.